Search Results - "Klepetko, W."

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by D'Addario, G., Früh, M., Reck, M., Baumann, P., Klepetko, W., Felip, E.

Get full text

Risk factors for chronic thromboembolic pulmonary hypertension by Bonderman, D, Wilkens, H, Wakounig, S, Schafers, H-J, Jansa, P, Lindner, J, Simkova, I, Martischnig, A. M, Dudczak, J, Sadushi, R, Skoro-Sajer, N, Klepetko, W, Lang, I. M

“…Chronic thromboembolic pulmonary hypertension (CTEPH) is characterised by nonresolving pulmonary thromboemboli that can be treated by surgical pulmonary…”
Get full text

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation by Benazzo, A., Bozzini, S., Auner, S., Berezhinskiy, H. Oya, Watzenboeck, M. L., Schwarz, S., Schweiger, T., Klepetko, W., Wekerle, T., Hoetzenecker, K., Meloni, F., Jaksch, P.

“…Alemtuzumab is a monoclonal antibody targeting CD52, used as induction therapy after lung transplantation (LTx). Its engagement produces a long-lasting…”
Get full text

Clinical Ex Vivo Lung Perfusion—Pushing the Limits by Aigner, C., Slama, A., Hötzenecker, K., Scheed, A., Urbanek, B., Schmid, W., Nierscher, F. J., Lang, G., Klepetko, W.

“…Ex vivo lung perfusion (EVLP) provides the ability to evaluate donor lungs before transplantation. Yet, limited prospective clinical data exist with regard to…”
Get full text

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension by Schermuly, R. T, Stasch, J-P, Pullamsetti, S. S, Middendorff, R, Muller, D, Schluter, K-D, Dingendorf, A, Hackemack, S, Kolosionek, E, Kaulen, C, Dumitrascu, R, Weissmann, N, Mittendorf, J, Klepetko, W, Seeger, W, Ghofrani, H. A, Grimminger, F

“…Alterations of the nitric oxide receptor, soluble guanylate cyclase (sGC) may contribute to the pathophysiology of pulmonary arterial hypertension (PAH). In…”
Get full text

Meprin β contributes to collagen deposition in lung fibrosis by Biasin, V., Wygrecka, M., Marsh, L. M., Becker-Pauly, C., Brcic, L., Ghanim, B., Klepetko, W., Olschewski, A., Kwapiszewska, G.

“…Lung fibrosis is a severe disease characterized by epithelial cell injury, inflammation and collagen deposition. The metalloproteases meprinα and meprinβ have…”
Get full text

SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis by Jayachandran, A, Königshoff, M, Yu, H, Rupniewska, E, Hecker, M, Klepetko, W, Seeger, W, Eickelberg, O

“…Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterised by accumulation of activated (myo)fibroblasts and excessive…”
Get more information

Quality of Life after Pediatric Lung Transplantation by Strasser, N., Gruber, S., Hoetzenecker, K., Klepetko, W., Szépfalusi, Z., Nachbaur, E.

“…In recent decades, pediatric lung transplantation has developed into a well-accepted therapy for children and adolescents as ultimate ratio for terminal lung…”
Get full text

Alemtuzumab in Lung Transplantation: An Open‐Label, Randomized, Prospective Single Center Study by Jaksch, P., Ankersmit, J., Scheed, A., Kocher, A., Muraközy, G., Klepetko, W., Lang, G.

“…Induction therapy with alemtuzumab followed by lower maintenance immunosuppression (IS) has been associated with reduced morbidity and mortality in abdominal…”
Get full text

Guidelines for the diagnosis and treatment of pulmonary hypertension by Galiè, N, Hoeper, M M, Humbert, M, Torbicki, A, Vachiery, J-L, Barbera, J A, Beghetti, M, Corris, P, Gaine, S, Gibbs, J S, Gomez-Sanchez, M A, Jondeau, G, Klepetko, W, Opitz, C, Peacock, A, Rubin, L, Zellweger, M, Simonneau, G

Get full text

High Altitude Mountaineering after Lung Transplantation - Jebel Toubkal Peak 4167m by Slama, A., Benazzo, A., Mühlbacher, J., Schrutka, L., Besa, V., Koch, A., Hoetzenecker, K., Klepetko, W., Aigner, C., Jaksch, P.

“…After successful lung transplantation, patients can potentially reach same strength and endurance as healthy individuals. Although high-altitude trekking has…”
Get full text

Pulmonary metastasectomy for soft tissue sarcoma – Report from a dual institution experience at the Medical University of Vienna by Schur, S, Hoetzenecker, K, Lamm, W, Koestler, W.J, Lang, G, Amann, G, Funovics, P, Nemecek, E, Noebauer, I, Windhager, R, Klepetko, W, Brodowicz, T

“…Abstract Background Pulmonary metastasectomy when possible has become therapeutic standard in soft tissue sarcoma patients. However, published reports…”
Get full text

Lung Transplantation for Acute Respiratory Distress Syndrome Patients: A Single Center Experience by Frick, A., Kifjak, D., Taghavi, S., Lang, G., Moser, B., Schwarz, S., Benazzo, A., Klepetko, W., Jaksch, P., Hoetzenecker, K.

“…Acute respiratory distress syndrome (ARDS) is a rapidly progressive lung disease with a high mortality rate. Although lung transplantation (LTx) remains the…”
Get full text

NPY/Y1 receptor‐mediated vasoconstrictory and proliferative effects in pulmonary hypertension by Crnkovic, S, Egemnazarov, B, Jain, P, Seay, U, Gattinger, N, Marsh, L M, Bálint, Z, Kovacs, G, Ghanim, B, Klepetko, W, Schermuly, R T, Weissmann, N, Olschewski, A, Kwapiszewska, G

“…Background and Purpose Pulmonary arteries (PAs) are innervated, but little is known about the role of neuronal axis in pulmonary hypertension (PH). Here, we…”
Get full text

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma by Ghanim, B, Hoda, M A, Klikovits, T, Winter, M-P, Alimohammadi, A, Grusch, M, Dome, B, Arns, M, Schenk, P, Jakopovic, M, Samarzija, M, Brcic, L, Filipits, M, Laszlo, V, Klepetko, W, Berger, W, Hegedus, B

“…Background: To investigate the clinical utility of pretreatment plasma fibrinogen levels in malignant pleural mesothelioma (MPM) patients. Methods: A…”
Get full text

NPY / Y 1 receptor‐mediated vasoconstrictory and proliferative effects in pulmonary hypertension by Crnkovic, S, Egemnazarov, B, Jain, P, Seay, U, Gattinger, N, Marsh, L M, Bálint, Z, Kovacs, G, Ghanim, B, Klepetko, W, Schermuly, R T, Weissmann, N, Olschewski, A, Kwapiszewska, G

“…Background and Purpose Pulmonary arteries ( PA s) are innervated, but little is known about the role of neuronal axis in pulmonary hypertension ( PH ). Here,…”
Get full text

Torque Teno Virus (TTV) Kinetics Can Predict Complications after Lung Transplantation by Jaksch, P., Benazzo, A., Schwarz, S., Gabriella, M., Hielle-Wittmann, E., Lambers, C., Hötzenecker, K., Klepetko, W., Görzer, I., Puchhammer-Stöckl, E.

“…New biomarkers reflecting the degree of immunosuppression in transplant recipients are needed to provide an optimal balance between risk for rejection and risk…”
Get full text

Respiratory Failure Treated by ECLS in Previously Unscreened Patients - Is Lung Transplantation Feasible? by Benazzo, A., Schwarz, S., Schweiger, T., Frick, A., Moser, B., Matilla, J., Lang, G., Taghavi, S., Jaksch, P., Klepetko, W., Hoetzenecker, K.

“…ECLS is increasingly used to bridge deteriorating candidates to LTx. Most centers would only bridge patients previously approved for Tx and on the waiting…”
Get full text

Outcome of Extracorporeal Photopheresis as Add-On Therapy in Patients for Antibody-Mediated Rejection after Lung Transplantation by Benazzo, A., Schwarz, S., Schweiger, T., Frick, A., Muraközy, G., Lambers, C., Moser, B., Matilla, J., Lang, G., Taghavi, S., Klepetko, W., Hoetzenecker, K., Jaksch, P.

“…The diagnosis and treatment of antibody-mediated rejection (AMR) after LTx has gained increasing recognition within the transplant community. Extracorporeal…”
Get full text

Liberal Use of Hemofiltration to Optimize Volume Status in iPAH Patients Does Not Impair Long-Term Kidney Function by Benazzo, A., Schwarz, S., Schweiger, T., Frick, A., Moser, B., Matilla, J., Lang, G., Taghavi, S., Jaksch, P., Klepetko, W., Hoetzenecker, K.

“…The post-operative phase after LTx for iPAH can be challenging. A restrictive fluid management facilitates unloading of the untrained left ventricle and…”
Get full text